BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22153533)

  • 1. Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers.
    Aghcheli K; Parsian H; Qujeq D; Talebi M; Mosapour A; Khalilipour E; Islami F; Semnani S; Malekzadeh R
    Eur J Intern Med; 2012 Jan; 23(1):58-64. PubMed ID: 22153533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
    Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
    Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assay of the laminin P1 using a radioimmunologic technic: applications in oncology].
    Larbre H; Loemba L; Deltour G
    Bull Cancer; 1989; 76(9):947-53. PubMed ID: 2620128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
    Birkenfeld S; Noiman G; Krispin M; Schwartz S; Zakut H
    Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient intake and risk of subtypes of esophageal and gastric cancer.
    Mayne ST; Risch HA; Dubrow R; Chow WH; Gammon MD; Vaughan TL; Farrow DC; Schoenberg JB; Stanford JL; Ahsan H; West AB; Rotterdam H; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1055-62. PubMed ID: 11588131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin levels in patients with esophageal cancer.
    Yildirim A; Bilici M; Cayir K; Yanmaz V; Yildirim S; Tekin SB
    Jpn J Clin Oncol; 2009 Feb; 39(2):92-6. PubMed ID: 19116211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
    Guo E; Chen L; Xie Q; Chen J; Tang Z; Wu Y
    Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
    Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
    Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran.
    Haghdoost AA; Hosseini H; Chamani G; Zarei MR; Rad M; Hashemipoor M; Zahedi MJ; Darvish-Moghadam S
    Arch Iran Med; 2008 Jul; 11(4):364-70. PubMed ID: 18588366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
    J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
    Shimada Y; Maeda M; Watanabe G; Imamura M
    Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
    Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
    Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case-control study.
    Akre O; Forssell L; Kaijser M; Norén-Nilsson I; Lagergren J; Nyrén O; Ekbom A
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):867-71. PubMed ID: 16702362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
    Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
    Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
    Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
    Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer].
    Kozuszko B; Skrzydlewski Z; Sulkowska M; Snarska J; Kozłowski M; Skrzydlewska E; Zalewski B
    Pol Merkur Lekarski; 2001 Sep; 11(63):218-20. PubMed ID: 11761814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.